Arrestins as Regulators of Kinases and Phosphatases - Progress in Molecular Biology and Translational Science - page 139

55. Gao H, Sun Y, Wu Y, et al. Identification of beta-arrestin2 as a G protein-coupled
receptor-stimulated regulator of NF-kappaB pathways. Mol Cell . 2004;14:303 - 317.
56. Fan H, Luttrell LM, Tempel GE, Senn JJ, Halushka PV, Cook JA. b -Arrestins 1 and 2
differentially regulate LPS-induced signaling and pro-inflammatory gene expression.
Mol Immunol . 2007;44:3092- 3099.
57. Beaulieu JM, Marion S, Rodriguiz RM, et al. A beta-arrestin 2 signaling complex
mediates lithium action on behavior. Cell . 2008;132:125- 136.
58. Kendall RT, Strungs EG, Rachidi SM, et al. The beta-arrestin pathway-selective type
1A angiotensin receptor (AT1A) agonist [Sar1, Ile4, Ile8]angiotensin II regulates a
robust G protein-independent signaling network. J Biol Chem . 2011;286:

19880 - 19891.
59. Miller WE, Maudsley S, Ahn S, Khan KD, Luttrell LM, Lefkowitz RJ. Beta-arrestin1
interacts with the catalytic domain of the tyrosine kinase c-SRC. Role of beta-
arrestin1-dependent

J Biol Chem .

targeting of c-SRC in receptor endocytosis.

2000;275:11312 - 11319.
60. Penela P, Elorza A, Sarnago S, Mayor Jr F. Beta-arrestin- and c-Src-dependent degra-
dation of G-protein-coupled receptor kinase 2. EMBO J . 2001;20:5129 - 5138.
61. Galet C, Ascoli M. Arrestin-3 is essential for the activation of Fyn by the luteinizing
hormone receptor (LHR) in MA-10 cells. Cell Signal . 2008;20:1822 - 2829.
62. Noma T, Lemaire A, Naga Prasad SV, et al. Beta-arrestin-mediated beta1-adrenergic
receptor transactivation of the EGFR confers cardioprotection. J Clin Invest .

2007;117:2445 - 2458.
63. Seta K, Nanamori M, Modrall JG, Neubig RR, Sadoshima J. AT1 receptor mutant
lacking heterotrimeric G protein coupling activates the Src-Ras-ERK pathway with-
out nuclear translocation of ERKs. J Biol Chem . 2002;277:9268 - 9277.
64. Gesty-Palmer D, El Shewy H, Kohout TA, Luttrell LM. Beta-arrestin 2 expression
determines the transcriptional response to lysophosphatidic acid stimulation in murine
embryo fibroblasts. J Biol Chem . 2005;280:32157 - 32167.
65. Sun Y, Cheng Z, Ma L, Pei G. Beta-arrestin2 is critically involved in CXCR4-
mediated chemotaxis, and this is mediated by its enhancement of p38 MAPK activa-
tion. J Biol Chem . 2002;277:49212 - 49219.
66. Bruchas MR, Macey TA, Lowe JD, Chavkin C. Kappa opioid receptor activation of
p38 MAPK is GRK3- and arrestin-dependent in neurons and astrocytes. J Biol Chem .
2006;281:18081 - 18089.
67. Zhao M, Wimmer A, Trieu K, Discipio RG, Schraufstatter IU. Arrestin regulates
MAPK activation and prevents NADPH oxidase-dependent death of cells expressing
CXCR2. J Biol Chem . 2004;279:49259 - 49267.
68. Goel R, Phillips-Mason PJ, Raben DM, Baldassare JJ. Alpha-thrombin induces rapid
and sustained Akt phosphorylation by beta-arrestin1-dependent and -independent
mechanisms, and only the sustained Akt phosphorylation is essential for G1 phase pro-
gression. J Biol Chem . 2002;277:18640 - 18648.
69. Yu MC, Su LL, Zou L, et al. An essential function for beta-arrestin 2 in the inhibitory
signaling of natural killer cells. Nat Immunol . 2008;9:898 - 907.
70. Wang P, DeFea KA. Protease-activated receptor-2 simultaneously directs beta-
arrestin-1-dependent

inhibition and Galphaq-dependent activation of pho-

sphatidylinositol 3-kinase. Biochemistry . 2006;45:9374 - 9385.
71. Nelson CD, Kovacs JJ, Nobles KN, Whalen EJ, Lefkowitz RJ. Beta-arrestin scaffolding
of phosphatidylinositol 4-phosphate 5-kinase Ialpha promotes agonist-stimulated
sequestration of the beta2-adrenergic receptor. J Biol Chem . 2008;283:21093 - 21101.
72. Whalen EJ, Rajagopal S, Lefkowitz RJ. Therapeutic potential of b -arrestin- and G
protein-biased agonists. Trends Mol Med. 2011;17:126 - 139.